NEW BATCH!

Blinatumomab

clinical grade

BATCH NUMBER: 1164206A

1.020,00 €

Therapeutic Blinatumomab antibody from the original Blincyto® commercial drug, from the Swiss market
Request For Quotation
Bulk deal
Quantity Discount
2 5%
3 10%
4 - 6 15%
7 + 25%

.

In stock

Product specifications:​

  • Quality Standard clinical-grade
  • Product Concentration 0,0125 mg/mL
  • Volume per vial 154 µL
  • Quantity per vial 0,002 mg
  • Origin of the commercial drug CH
  • Batch Number 1164206A
  • Storage Temperature -80°C
  • Original therapeutic expiry date: 07/2027

Our products are for research use only. The “therapeutic expiration date” implies expiry date for patient adminstration and is not applicable to the shelf life of the aliquot. Aliquot storage at -86°C ensures fully functional molecules even after the mentioned expiry date.

Product Information:

Evidentic offers repackaged finished pharmaceutical products (e.g RMP/RLD). We refer to the repackaged RMP/RLD products synonymously as drug aliquots or aRMP, or short: aliquots.

We offer batches of original drug aliquots in low-binding Eppendorf tubes for research use only. We provide license-free drug aliquots with long, short or even “negative shelf life” by storing the products at recommended temperatures (either 2-8°C or -80°C) and ensuring fully functional molecules for research purposes.

As ‘raw material’ for the production of drug aliquots, Evidentic sources RMP from the European (EU) market. As a licensed pharmaceutical wholesaler, Evidentic is committed to Good Distribution Practice (GDP) compliance with respect to the procurement, storage and shipment of RMP.
Drug aliquots are manufactured by repackaging RMP in a qualified laboratory. The aliquotation process is performed under a quality and manufacturing agreement between Evidentic and the contract manufacturer. Repackaging of RMP includes the following steps: opening the secondary and primary RMP containers and transferring the specified volumes of RMP into an Eppendorf 0.5 ml low-binding (or similar) tube. If the RMP is a lyophilized powder and not a highly concentrated solution, reconstitute the RMP according to the original manufacturer’s instructions and then aliquot as a highly concentrated solution.
For identification purposes, drug aliquots are labeled with the date of aliquoting, the original lot number of the RMP, the original expiration date of the RMP, the name of the active ingredient (INN), and a unique identification code.
Immediately after aliquoting, drug aliquots are stored at either 2-8 °C or -86 °C for long-term storage. All drug aliquots stored at 2-8 °C are transferred to -86 °C at least two weeks before the expiration date of the original RLD/RMP is reached. Further quality or functional testing are not performed on the drug aliquots.  

Target

,

Class of molecule

Isotype

Host cells

Chinese Hamster Ovary (CHO) cells

Prepared from (Reference drug)​

Blincyto®

Therapeutic Area

Therapeutic Indications

Mechanism of Action (MoA)

Blinatumomab mediates the formation of a cytolytic synapse between the T-cell and the tumour cell, releasing proteolytic enzymes to kill both proliferating and resting target cells. Blinatumomab is associated with transient upregulation of cell adhesion molecules, production of cytolytic proteins, release of inflammatory cytokines, and proliferation of T-cells, and results in elimination of CD19+ cells.

Pharmacotherapeutic group​​

Antineoplastic agents

List of Excipients​

Citric acid monohydrate (E330)
Trehalose dihydrate
Lysine hydrochloride
Polysorbate 80
Sodium hydroxide (for pH-adjustment)

Batch specific analytical data available

Evidentic’s analytical service includes a comprehensive array of methods to support the drug development process, including, for example, structure, aggregation, degree of isomerization and N-glycans identification of the active pharmaceutical ingredient (API).

Blinatumomab

BATCH NUMBER: 1164206A

Request an individual offer​

+ download a free sample​

1. Choose your(s) method(s) of interest
2. Provide your contact details
3. Send us your request and download a free sample report


Please provide your contact information


send us your inquiry and download a free sample file


  • Target research – Target identification, selection & validation
  • Planning and screening preparation
  • Lead generation – Screening preparation, hit generation, screening & lead selection
  • Lead optimization – Lead characterization, candidate selection
  • Preclinical development – PK/PD studies of candidate

More , Reference Drugs as Aliquots

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
Amivantamab MAS0001
EGFR
,
MET
Bispecific Antibody
Rybrevant®
50 mg/ml
–
7 mg
-80°C
11/2023
328,50 €
view product
Max: 3
Min: 1
Step: 1
Emicizumab B4125B27
Clotting Factor IXa and X
Bispecific Antibody
Hemlibra®
30 mg/mL
–
2 mg
-80°C
09/2023
727,00 €
view product
Max: 7
Min: 1
Step: 1
Emicizumab B4164B18
Clotting Factor IXa and X
Bispecific Antibody
Hemlibra®
30 mg/mL
–
2 mg
-80°C
08/2024
727,00 €
view product
Max: 10
Min: 1
Step: 1
Faricimab
VEGF-A
Monoclonal Antibody
Vabysmo®
120 mg/mL
–
2.4 mg
tba
tba
618,00 €
view product
Max: 50
Min: 5
Step: 1
Mosunetuzumab
CD20
,
CD3
Bispecific Antibody
Lunsumio®
1 mg/mL
–
0.05 mg
tba
tba
316,00 €
view product
Max: 10
Min: 7
Step: 1
Tebentafusp
CD3
,
TCR targeting domain
Bispecific fusion protein
Kimmtrak®
0,2 mg/mL
–
0.01 mg
tba
tba
4.602,00 €
view product
Max:
Min: 4
Step: 1

VIEW MORE NEW BATCHES!

Not looking for Blinatumomab 1164206A?

Search our therapeutic molecules product database

Quick Ordering

Find and order your therapeutic molecules through smart filters

Multiple Batches

Up to 10 batches of original drugs for examining batch-to-batch variations

Reduce Costs

Up to 80% less compared to the original pharmaceutical price

Worldwide Shipping

Shipment within days worldwide according to GDP-standards

Precise Quantity​​

Up to 80% less compared to the original pharmaceutical price

Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin

+49 (0) 30 959 99 8831
info@evidentic.com

Cookie Preferences

Linkedin Youtube Facebook Twitter Instagram

Thank you for your interest in our services.

We will respond to you within one working day. You can now download your sample report.